Pratiques de curarisation/décurarisation et impact des modalités de décurarisation sur les durées en salle opératoire et SSPI – résultats d’une enquête Delphi

[1]  T. Oh,et al.  Retrospective analysis of 30‐day unplanned readmission after major abdominal surgery with reversal by sugammadex or neostigmine , 2019, British journal of anaesthesia.

[2]  P. Boizeau,et al.  Combien faut-il d’experts dans une enquête Delphi ? Étude de simulation , 2017 .

[3]  A. Galarneau,et al.  A discrete event simulation model of clinical and operating room efficiency outcomes of sugammadex versus neostigmine for neuromuscular block reversal in Canada , 2016, BMC Anesthesiology.

[4]  G. Servillo,et al.  The use of sugammadex for bariatric surgery: analysis of recovery time from neuromuscular blockade and possible economic impact , 2016, ClinicoEconomics and outcomes research : CEOR.

[5]  F. Zarantonello,et al.  Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center , 2016, ClinicoEconomics and outcomes research : CEOR.

[6]  C. Fernández-Pérez,et al.  A systematic review of sugammadex vs neostigmine for reversal of neuromuscular blockade , 2015, Anaesthesia.

[7]  T. Maher,et al.  Development of a Consensus Statement for the Definition, Diagnosis, and Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis Using the Delphi Technique , 2015, Advances in Therapy.

[8]  C. Meistelman,et al.  Sugammadex: A Scientific Review Including Safety and Efficacy, Update on Regulatory Issues, and Clinical Use in Europe. , 2015, American journal of therapeutics.

[9]  B. Romito,et al.  Sugammadex: A Comprehensive Review of the Published Human Science, Including Renal Studies. , 2015, American journal of therapeutics.

[10]  D. Longrois,et al.  Analyse des dépenses de curares et de sugammadex après une année d’utilisation en routine clinique , 2011 .

[11]  J. A. Ariño Irujo.  [Residual neuromuscular blockade]. , 2011, Revista espanola de anestesiologia y reanimacion.

[12]  D. Chambers,et al.  Sugammadex compared with neostigmine/glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. , 2010, British journal of anaesthesia.

[13]  D. Chambers,et al.  Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. , 2010, British journal of anaesthesia.

[14]  J. Scholz,et al.  Reversal of rocuronium-induced neuromuscular blockade with sugammadex compared with neostigmine during sevoflurane anaesthesia: results of a randomised, controlled trial , 2010, European journal of anaesthesiology.

[15]  W. Sandberg,et al.  Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. , 2010, British journal of anaesthesia.

[16]  S. Brull,et al.  A Survey of Current Management of Neuromuscular Block in the United States and Europe , 2010, Anesthesia and analgesia.

[17]  C. Meistelman,et al.  Monitorage de la curarisation et prévention de la curarisation résiduelle , 2009 .

[18]  D. Grobbee,et al.  Impact of Anesthesia Management Characteristics on Severe Morbidity and Mortality , 2005, Anesthesiology.

[19]  L. Eriksson.  Evidence-based practice and neuromuscular monitoring: it's time for routine quantitative assessment. , 2003, Anesthesiology.

[20]  J. Viby-Mogensen.  Postoperative residual curarization and evidence-based anaesthesia. , 2000, British journal of anaesthesia.

[21]  D. Hunter,et al.  Qualitative Research: Consensus methods for medical and health services research , 1995 .